Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO)
NCT ID: NCT03580421
Last Updated: 2022-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
77 participants
INTERVENTIONAL
2018-08-01
2022-06-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that ambulatory surgery versus standard pathway in the management of endometrial cancer is both safe, feasible and may impact on patient health-related quality of life.
The main objective of the study is to assess the cost-utility of ambulatory surgery versus standard pathway in the management of endometrial cancer.
A total of 252 consecutive, eligible, consenting patients with a low- and intermediate-risk early stage endometrial cancer will be enrolled from various clinical practice sites within France and patient will randomly be assigned to one of the two surgical management pathways: ambulatory pathway versus standard pathway.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A short hospital stay decreases the risk of exposure to hospital infections, causes less disruption to the patient's personal life, results in potential cost savings for patients and relatives, as well as for hospitals, and there is positive feedback regarding the social environment of patients as they return rapidly to daily activities and work.
To date, safety, feasibility and cost-utility of ambulatory surgery versus traditional pathway in the management of endometrial cancer have never been prospectively assessed.
The investigators hypothesize that ambulatory surgery versus standard pathway in the management of endometrial cancer is both safe, feasible and may impact on patient health-related quality of life.
The main objective of the study is to assess the cost-utility of ambulatory surgery versus standard pathway in the management of endometrial cancer.
A total of 252 consecutive, eligible, consenting patients with a low, intermediate- and high-risk early stage endometrial cancer will be enrolled from various clinical practice sites within France and patient will randomly be assigned to one of the two surgical management pathways: ambulatory pathway versus standard pathway.
Preoperative and postoperative protocols (including geriatric and dietetic evaluation, and anesthesia and nursing consultation) will be applied for optimizing same-day discharge of patients randomly assigned to ambulatory surgery.
Data will be collected in conjunction with usual care visit, 1 month after initial surgery.
The economic evaluation will closely follow the 2011 French National Authority for Health (HAS) economic evaluation guidelines and the evaluation proposal will have three complementary parts with a full cooperation between those involved in the evaluation:
First, the economic evaluation will focus on evaluating the cost-utility profile of ambulatory surgery in endometrial cancer in France. This economic evaluation will include a micro-costing study to estimate by direct observation the cost of resources used during the ambulatory pathway, and the total cost of patients' care in each group. The primary endpoint will be the incremental cost-utility ratio using the 30-day health related quality of life. It will be calculated for both groups using health-related quality of life (HRQoL) scores from the EQ-5D and converted to utility scores using French weights. QALYs will be computed at 30 days (primary analysis) using both mortality and HRQoL scores.
Second, the investigators will perform an analysis of patients' and professionals' preferences about ambulatory care pathways. These preferences will be analyzed in depth, using both surveys and recent tools developed in experimental economics. Health care professionals' views and preferences will be collected, using questionnaires and face-to-face interviews both at the beginning of the study (M0). Patients' preferences will be assessed using a Discrete Choice Experiment (DCE) method, which is increasingly used in health economics.
Third, a thorough analysis of the ethical and inequality aspects tied to the development of ambulatory surgery in endometrial cancer will be developed, following the methodological guidance issued in 2013 by the HAS. Special emphasis will be laid on equity issues in the measurement of patients' benefits, using a capability approach (ICECAP-A questionnaire).
Finally, another secondary objective will be to assess the safety and feasibility of ambulatory surgery versus traditional pathway in the management of endometrial cancer, and to validate biomarkers of high risk of nodal involvement in a translational study (complementary budget will be asked for this part).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard pathway group
this group will benefit from standard care including: one surgical consultation, one anesthesia consultation, surgery followed by 2-4 days of hospitalization and most of the time 3 post-operative consultations (M1, M6, M12) during the first operative year
standard surgery
total hysterectomy and bilateral salpingo-oophorectomy with or without lymphadenectomy
ambulatory pathway group
Preoperative and postoperative protocols will be applied for optimizing same-day discharge. Gynaecologists, anaesthetists, and nursing staff will work as a team. A specific anesthesia consultation will focus on ambulatory surgery management. A geriatric evaluation will be offered to women over 70 years old with a score ≤14 according to G8 screening tool. A dietetic evaluation will be offered to women with BMI ≥ 35. A nursing consultation will be offered, as patient and their family preparation prior to ambulatory surgery is important.
ambulatory surgery
total hysterectomy and bilateral salpingo-oophorectomy with or without lymphadenectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ambulatory surgery
total hysterectomy and bilateral salpingo-oophorectomy with or without lymphadenectomy
standard surgery
total hysterectomy and bilateral salpingo-oophorectomy with or without lymphadenectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women affiliated to the social security (including CMU)
* Women understanding the French language
* Women with preoperative endometrial biopsy and preoperative MRI to assess disease stage
* Women with stage I or II endometrial cancer according to the 2009 International Federation of Gynecology and Obstetrics (FIGO) classification
* Women eligible for surgery including laparoscopic or vaginal total hysterectomy and bilateral salpingo-oophorectomy with or without nodal staging (i.e., sentinel lymph node biopsy +/- pelvic lymphadenectomy)
* informed consent signed
* pregnant or breast-feeding patient
Exclusion Criteria
* Women eligible for surgery including nodal staging with para-aortic lymphadenectomy
* Significantly enlarged uterus that prevent intact vaginal removal or will require a laparotomy which may limit ambulatory management (uterine size larger than 10 weeks of gestation)
* Cardiovascular disease (including participants with pacemakers), pulmonary disease
* Estimated life expectancy less than 12 months
* Medically unfit for surgery
* Patient unfit to complete questionnaire
* A history of conversion to laparotomy for lysis of adhésions or significant lysis of adhesions during a surgery
* Previous lymphadenectomy.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ecole d'econmie de Paris (PSE)-Hospinnomics
UNKNOWN
Université Montpellier
OTHER
Université de Rennes 1 CREM CNRS UMR 6211
UNKNOWN
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Geoffroy CANLORBE, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Lise ROCHAIX, MD PHD
Role: STUDY_DIRECTOR
Hospinnomics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Chirurgie Gynécologique Obstétrique Reproduction Humaine
Clermont-Ferrand, , France
CHIC - Gynécologie-Obstétrique-Maternité
Créteil, , France
Service de chirurgie gynécologique, Centre de lutte contre le cancer
Dijon, , France
Service de chirurgie gynécologique, Centre Hospitalier Simone Veil
Eaubonne, , France
Service de chirurgie gynécologique, hôpital Pitié-salpêtrière
Paris, , France
HEGP - Chirurgie Cancérologique Gynécologique et du Sein
Paris, , France
Hôpital Bichat-Claude Bernard Gynécologie obstétrique
Paris, , France
Service de chirurgie gynécologique, hôpital Tenon
Paris, , France
IGR - Comité d'Oncologie Gynécologique
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02835-48
Identifier Type: REGISTRY
Identifier Source: secondary_id
P150966
Identifier Type: -
Identifier Source: org_study_id